Literature DB >> 16467148

Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction.

Bilal B Ayach1, Makoto Yoshimitsu, Fayez Dawood, Mei Sun, Sara Arab, Manyin Chen, Koji Higuchi, Christopher Siatskas, Paul Lee, Hilda Lim, Jane Zhang, Eva Cukerman, William L Stanford, Jeffrey A Medin, Peter P Liu.   

Abstract

Inappropriate cardiac remodeling and repair after myocardial infarction (MI) predisposes to heart failure. Studies have reported on the potential for lineage negative, steel factor positive (c-kit+) bone marrow-derived hematopoetic stem/progenitor cells (HSPCs) to repair damaged myocardium through neovascularization and myogenesis. However, the precise contribution of the c-kit signaling pathway to the cardiac repair process has yet to be determined. In this study, we sought to directly elucidate the mechanistic contributions of c-kit+ bone marrow-derived hematopoetic stem/progenitor cells in the maintenance and repair of damaged myocardium after MI. Using c-kit-deficient mice, we demonstrate the importance of c-kit signaling in preventing ventricular dilation and hypertrophy, and the maintenance of cardiac function after MI in c-kit-deficient mice. Furthermore, we show phenotypic rescue of cardiac repair after MI of c-kit-deficient mice by bone marrow transplantation of wild-type HSPCs. The transplanted group also had reduced apoptosis and collagen deposition, along with an increase in neovascularization. To better understand the mechanisms underlying this phenotypic rescue, we investigated the gene expression pattern within the infarcted region by using microarray analysis. This analysis suggested activation of inflammatory pathways, specifically natural killer (NK) cell-mediated mobilization after MI in rescued hearts. This finding was confirmed by immunohistology and by using an NK blocker. Thus, our investigation revealed a previously uncharacterized role for c-kit signaling after infarction by mediating bone marrow-derived NK and angiogenic cell mobilization, which contributes to improved remodeling and cardiac function after MI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16467148      PMCID: PMC1413746          DOI: 10.1073/pnas.0510997103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Minimum information about a microarray experiment (MIAME)-toward standards for microarray data.

Authors:  A Brazma; P Hingamp; J Quackenbush; G Sherlock; P Spellman; C Stoeckert; J Aach; W Ansorge; C A Ball; H C Causton; T Gaasterland; P Glenisson; F C Holstege; I F Kim; V Markowitz; J C Matese; H Parkinson; A Robinson; U Sarkans; S Schulze-Kremer; J Stewart; R Taylor; J Vilo; M Vingron
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

Review 2.  What does it take to make a natural killer?

Authors:  Francesco Colucci; Michael A Caligiuri; James P Di Santo
Journal:  Nat Rev Immunol       Date:  2003-05       Impact factor: 53.106

3.  Little evidence for developmental plasticity of adult hematopoietic stem cells.

Authors:  Amy J Wagers; Richard I Sherwood; Julie L Christensen; Irving L Weissman
Journal:  Science       Date:  2002-09-05       Impact factor: 47.728

4.  Adult cardiac stem cells are multipotent and support myocardial regeneration.

Authors:  Antonio P Beltrami; Laura Barlucchi; Daniele Torella; Mathue Baker; Federica Limana; Stefano Chimenti; Hideko Kasahara; Marcello Rota; Ezio Musso; Konrad Urbanek; Annarosa Leri; Jan Kajstura; Bernardo Nadal-Ginard; Piero Anversa
Journal:  Cell       Date:  2003-09-19       Impact factor: 41.582

Review 5.  The inflammatory response in myocardial infarction.

Authors:  Nikolaos G Frangogiannis; C Wayne Smith; Mark L Entman
Journal:  Cardiovasc Res       Date:  2002-01       Impact factor: 10.787

Review 6.  Stem cell factor: laboratory and clinical aspects.

Authors:  M A Smith; E L Court; J G Smith
Journal:  Blood Rev       Date:  2001-12       Impact factor: 8.250

7.  Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells.

Authors:  K A Jackson; S M Majka; H Wang; J Pocius; C J Hartley; M W Majesky; M L Entman; L H Michael; K K Hirschi; M A Goodell
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

8.  Temporal response and localization of integrins beta1 and beta3 in the heart after myocardial infarction: regulation by cytokines.

Authors:  Mei Sun; M Anne Opavsky; Duncan J Stewart; Marlene Rabinovitch; Fayez Dawood; Wen-Hu Wen; Peter P Liu
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

9.  Bone marrow cells regenerate infarcted myocardium.

Authors:  D Orlic; J Kajstura; S Chimenti; I Jakoniuk; S M Anderson; B Li; J Pickel; R McKay; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Nature       Date:  2001-04-05       Impact factor: 49.962

10.  Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts.

Authors:  Abeel A Mangi; Nicolas Noiseux; Deling Kong; Huamei He; Mojgan Rezvani; Joanne S Ingwall; Victor J Dzau
Journal:  Nat Med       Date:  2003-08-10       Impact factor: 53.440

View more
  46 in total

Review 1.  Cardiac mast cells: the centrepiece in adverse myocardial remodelling.

Authors:  Scott P Levick; Giselle C Meléndez; Eric Plante; Jennifer L McLarty; Gregory L Brower; Joseph S Janicki
Journal:  Cardiovasc Res       Date:  2010-08-24       Impact factor: 10.787

Review 2.  Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes.

Authors:  Thomas Force; Kyle L Kolaja
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

3.  Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1alpha delivery and endogenous cytokine signaling.

Authors:  Tiemin Zhao; Dongsheng Zhang; Ronald W Millard; Muhammad Ashraf; Yigang Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

Review 4.  Cardiotoxicity due to cancer therapy.

Authors:  Aarif Y Khakoo; Peter P Liu; Thomas Force; Gabriel Lopez-Berestein; Lee W Jones; Jay Schneider; Joseph Hill
Journal:  Tex Heart Inst J       Date:  2011

5.  Divergent effects of losartan and metoprolol on cardiac remodeling, c-kit+ cells, proliferation and apoptosis in the left ventricle after myocardial infarction.

Authors:  Raisa Serpi; Anna-Maria Tolonen; Olli Tenhunen; Oskari Pieviläinen; Anna-Maria Kubin; Tommi Vaskivuo; Ylermi Soini; Risto Kerkelä; Hanna Leskinen; Heikki Ruskoaho
Journal:  Clin Transl Sci       Date:  2009-12       Impact factor: 4.689

6.  Exploiting natural anti-tumor immunity for metastatic renal cell carcinoma.

Authors:  Katherine A Murphy; Britnie R James; Yue Guan; Donald S Torry; Andrew Wilber; Thomas S Griffith
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

7.  Stem cell factor gene transfer improves cardiac function after myocardial infarction in swine.

Authors:  Kiyotake Ishikawa; Kenneth Fish; Jaume Aguero; Elisa Yaniz-Galende; Dongtak Jeong; Changwon Kho; Lisa Tilemann; Lauren Fish; Lifan Liang; Ahmed A Eltoukhy; Daniel G Anderson; Krisztina Zsebo; Kevin D Costa; Roger J Hajjar
Journal:  Circ Heart Fail       Date:  2014-10-23       Impact factor: 8.790

Review 8.  Natural killer cells in inflammatory heart disease.

Authors:  SuFey Ong; Noel R Rose; Daniela Čiháková
Journal:  Clin Immunol       Date:  2016-11-25       Impact factor: 3.969

Review 9.  Communication in the heart: the role of the innate immune system in coordinating cellular responses to ischemic injury.

Authors:  Slava Epelman; Douglas L Mann
Journal:  J Cardiovasc Transl Res       Date:  2012-10-05       Impact factor: 4.132

10.  Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium.

Authors:  Dongsheng Zhang; Guo-Chang Fan; Xiaoyang Zhou; Tiemin Zhao; Zeeshan Pasha; Meifeng Xu; Yi Zhu; Muhammad Ashraf; Yigang Wang
Journal:  J Mol Cell Cardiol       Date:  2007-12-07       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.